Lauren P Silvernail's Net Worth
$6.67 Million
Who is Lauren P Silvernail?
Lauren P Silvernail has an estimated net worth of $6.67 Million. This is based on reported shares across multiple companies, which include HARROW, INC., Revance Therapeutics, Inc., Evolus, Inc., Harpoon Therapeutics, Inc., and ISTA PHARMACEUTICALS INC.
SEC CIK
Lauren P Silvernail's CIK is 0001225755
Past Insider Trading and Trends
2011 was Lauren P Silvernail's most active year for acquiring shares with 11 total transactions. Lauren P Silvernail's most active month to acquire stocks was the month of January. 2012 was Lauren P Silvernail's most active year for disposing of shares, totalling 32 transactions. Lauren P Silvernail's most active month to dispose stocks was the month of April. 2009 saw Lauren P Silvernail paying a total of $2,266,338.52 for 56,000 shares, this is the most they've acquired in one year. In 2012 Lauren P Silvernail cashed out on 812,072 shares for a total of $3,792,103.82, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
HARROW, INC. (HROW) Snapshot price: $37.98
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Revance Therapeutics, Inc. (RVNC) Snapshot price: $6.56
CFO & CBO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -4.20% | -2.87K |
$30.25 | -$86,924.42 | 65.5K |
Scheduled
|
May 22
| ||
Form 4
| -4.78% | -3.43K |
$30.85 | -$105,838.80 | 68.37K |
Scheduled
|
Mar 22
| ||
Form 4
| -1.58% | -1.15K |
$21.54 | -$703,829.40 | 71.8K |
Scheduled
|
Mar 13 - Mar 15
| ||
Form 4
|
—
|
0
|
$20.35 | -$466,000.00 | 72.95K |
Scheduled
|
Mar 7 - Mar 9
| ||
Form 4
| -1.53% | -1.14K |
$31.75 | -$36,068.00 | 72.95K |
Feb 15
| |||
Form 4
| +12.32% | 8.13K |
—
|
—
| 74.09K |
Feb 8
| |||
Form 4
| -1.48% | -990.00 |
$33.50 | -$33,165.00 | 65.97K |
Jan 28
| |||
Form 4
| +0.67% | 443 |
$22.99 | $10,185.68 | 66.95K |
Dec 29
| |||
Form 4
| +35.72% | 17.51K |
$8.70 | $152,302.20 | 66.51K |
Dec 26
| |||
Form 4
|
—
|
0
|
$17.77 | -$181,267.00 | 49.01K |
Scheduled
|
Nov 7
| ||
Form 4
| -18.55% | -11.16K |
$26.67 | -$297,759.51 | 49.01K |
Scheduled
|
Oct 12
| ||
Form 4
| +1.01% | 604 |
$18.32 | $11,063.77 | 60.17K |
Jun 30
| |||
Form 4
| +62.90% | 23K |
$8.70 | $200,100.00 | 59.57K |
May 26
| |||
Form 4
| -4.67% | -1.79K |
$20.20 | -$36,212.15 | 36.57K |
May 22
| |||
Form 4
| -3.20% | -1.27K |
$19.20 | -$24,365.82 | 38.36K |
Mar 16
| |||
Form 4
| +29.12% | 8.94K |
$20.00 | -$21,260.00 | 39.63K |
Jan 26 - Jan 28
| |||
Form 4
| +2.50% | 749 |
$11.56 | $8,658.44 | 30.69K |
Jun 30
| |||
Form 4
| -5.53% | -1.75K |
$17.11 | -$29,993.83 | 29.94K |
May 19
| |||
Form 4
| +46.09% | 10K |
—
|
—
| 31.7K |
Feb 2
| |||
Form 4
| -4.67% | -1.06K |
$20.30 | -$21,578.90 | 21.7K |
Jan 28
| |||
Form 4
| +1.51% | 339 |
$27.00 | $9,153.00 | 22.76K |
Dec 31
| |||
Form 4
|
∞
| 633 |
$14.16 | $8,963.28 | 633 |
Jun 30
| |||
Form 4
| -7.53% | -1.75K |
$25.94 | -$45,472.82 | 21.52K |
May 19
| |||
Form 4
| +45.62% | 7.29K |
—
|
—
| 23.27K |
Jan 28
| |||
Form 4
| +7.00% | 980 |
$17.74 | $17,383.20 | 14.98K |
Dec 11
| |||
Form 4
|
∞
| 14K |
$32.22 | $451,080.00 | 14K |
May 19
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Evolus, Inc. (EOLS) Snapshot price: $14.71
See Remarks
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -32.51% | -68.20K |
$12.78 | -$871,380.42 | 141.57K |
May 17 - May 18
| |||
Form 4
| -4.63% | -10.19K |
$9.73 | -$99,121.28 | 209.78K |
Scheduled
|
Mar 8
| ||
Form 4
| +32.19% | 53.57K |
—
|
—
| 219.97K |
Jan 24
| |||
Form 4/A
| -7.91% | -14.29K |
$11.18 | -$159,774.30 | 166.4K |
Scheduled
|
Aug 10
| ||
Form 4
| +7.91% | 14.29K |
$11.18 | $159,774.30 | 194.98K |
Scheduled
|
Aug 10
| ||
Form 4
| +99.24% | 90K |
—
|
—
| 180.69K |
Jan 27
| |||
Form 4
| -2.89% | -2.70K |
$7.46 | -$20,134.54 | 90.69K |
Scheduled
|
Jan 25
| ||
Form 4
| +74.92% | 40K |
—
|
—
| 93.39K |
May 13
| |||
Form 4
| +94.93% | 26K |
—
|
—
| 53.39K |
Jan 23
| |||
Form 4
| -8.71% | -2.61K |
$13.53 | -$35,352.11 | 27.39K |
May 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
|
∞
| 30K |
—
|
—
| 30K |
May 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Harpoon Therapeutics, Inc. (HARP) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -5.00K |
—
|
—
|
0
|
Mar 11
| |||
Form 4
|
∞
| 5K |
—
|
—
| 5K |
Nov 27
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ISTA PHARMACEUTICALS INC No price found
CFO & VP Corporate Development
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -187.14K |
$9.10 | -$1,702,983.10 |
0
|
Jun 6
| |||
Form 4
| +54.46% | 65.24K |
$7.05 | $13.50 | 185.02K |
May 8
| |||
Form 4
| -1.81% | -2.21K |
$8.16 | -$18,050.72 | 119.78K |
Feb 7 - Feb 8
| |||
Form 4
| -1.52% | -1.88K |
$8.20 | -$15,448.80 | 122K |
Feb 2 - Feb 3
| |||
Form 4
| +28.37% | 27.38K |
—
| $27.38 | 123.88K |
Nov 30
| |||
Form 4
| +2.66% | 2.5K |
$4.28 | $10,704.60 | 96.5K |
Aug 11
| |||
Form 4
| +43.87% | 28.67K |
$7.20 | -$186,989.11 | 94K |
May 10
| |||
Form 4
| -1.66% | -1.10K |
$7.48 | -$8,257.92 | 65.34K |
Feb 8
| |||
Form 4
| +19.73% | 10.95K |
—
| $10.95 | 66.44K |
Feb 7
| |||
Form 4
| -2.89% | -1.68K |
$6.15 | -$10,344.30 | 56.44K |
Feb 2
| |||
Form 4
| -1.68% | -946.00 |
$6.20 | -$5,865.20 | 55.49K |
Feb 3
| |||
Form 4
| -0.87% | -513.00 |
$3.96 | -$2,031.48 | 58.12K |
Feb 16
| |||
Form 4
| -1.61% | -962.00 |
$3.59 | -$3,453.58 | 58.63K |
Feb 8
| |||
Form 4
| -1.63% | -989.00 |
$3.60 | -$3,560.40 | 59.59K |
Feb 3
| |||
Form 4
| +15.72% | 8.23K |
$3.63 | -$2,782.47 | 60.58K |
Feb 2
| |||
Form 4
| +20.76% | 9K |
—
| $9.00 | 52.35K |
Feb 3
| |||
Form 4
| +64.51% | 17K |
$0.63 | $10,698.10 | 43.35K |
Dec 9
| |||
Form 4/A
| -4.37% | -747.00 |
$5.27 | -$3,936.69 | 16.35K |
Feb 4
| |||
Form 4
| -1.87% | -500.00 |
$4.56 | -$2,280.00 | 26.27K |
Feb 19
| |||
Form 4
| +64.54% | 10.5K |
—
| $10.50 | 26.77K |
Feb 8
| |||
Form 4
| -4.86% | -831.00 |
$5.27 | -$4,379.37 | 16.27K |
Feb 4
| |||
Form 4
| +242.00% | 12.1K |
$8.11 | -$4,042.40 | 17.1K |
Feb 16 - Feb 16
| |||
Form 4
| +78.64% | 5.6K |
—
| $5.60 | 12.72K |
Feb 16
| |||
Form 4
|
∞
| 5K |
$7.54 | $37,699.00 | 5K |
May 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 10 - Feb 5
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||